[Federal Register Volume 70, Number 224 (Tuesday, November 22, 2005)]
[Notices]
[Page 70623]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-23041]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2005N-0343]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Guidance for Requesting an Extension 
to Use Existing Label Stock After the Trans Fat Labeling Effective Date 
of January 1, 2006

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Guidance for Requesting an 
Extension to Use Existing Label Stock after the Trans Fat Labeling 
Effective Date of January 1, 2006'' has been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995 
(the PRA). Elsewhere in this issue of the Federal Register, FDA is 
publishing a notice announcing an opportunity for public comment on 
this collection of information. Since this collection received 
emergency approval that expires on January 1, 2006, FDA is following 
the normal PRA clearance procedures by issuing that notice.

FOR FURTHER INFORMATION CONTACT: Peggy Robbins, Office of Management 
Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-1223.

SUPPLEMENTARY INFORMATION: In the Federal Register of September 1, 2005 
(70 FR 52108), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0571. 
The approval expires on January 31, 2006. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.fda.gov/ohrms/dockets.

    Dated: November 14, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05-23041 Filed 11-21-05; 8:45 am]
BILLING CODE 4160-01-S